NPR News

Republican strategist Karl Rove's on-air refusal to accept his own network's election night call putting Ohio in President Obama's win column dominated the blogosphere Wednesday.

And, why not? Rove's Crossroads political money empire had showered Republican candidates with close to $300 million this election cycle, a funding gusher courtesy of the 2010 Supreme Court's Citizens United decision and other recent court decisions.

We report on the morning after the election in Ohio, a pivotal swing state in the presidential election.

This presidential election attracted $1.5 billion in outside spending — TV ads, robocalls and other political activity by groups created to take advantage of the new rules of campaign finance law.

On the day after the voting, the track record of the groups, most of them conservative, is open to question.

Tuesday night was a rough one for Karl Rove. The GOP guru is the guiding light and chief fundraiser for the biggest outside spender: the twin groups American Crossroads and Crossroads GPS.

In the Election Day scramble you might have missed that Pfizer got a new drug approved for rheumatoid arthritis.

Pfizer expects the twice-a-day pill called Xeljanz will be available in pharmacies later this month.

The drug won't come cheap. The wholesale price will run about $2,000 for a month's supply, the company says.

In historic moves, Colorado and Washington state voted to legalize recreational use of marijuana on Tuesday. Its sale will be regulated and taxed, with some of the money going for drug education.